You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine tumors

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)

Not yet recruiting
  • Neuroendocrine Tumors
  • Lutetium[177Lu] Oxodotreotide Injection
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 30, 2023

Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 19, 2023

Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)

Completed
  • Recurrent Neuroendocrine Tumor
  • Metastatic Neuroendocrine Tumor
  • Cleveland, Ohio
    Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
Dec 1, 2022

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting
  • Neuroendocrine Tumors
  • +8 more
  • Iowa City, Iowa
  • +1 more
Nov 23, 2022

Neuroendocrine Tumors Trial (Lutathera)

Not yet recruiting
  • Neuroendocrine Tumors
  • (no location specified)
Aug 9, 2023

Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

Recruiting
  • Neuroendocrine Tumors
  • Carcinoma, Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma Trial (177Lu-DOTATOC)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +2 more
    • (no location specified)
    Sep 13, 2023

    Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)

    Completed
    • Neuroendocrine Tumors
    • Innsbruck, Austria
      Department of Nuclear Medicine, Medical University of Innsbruck
    Nov 24, 2023

    Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 13, 2023

    Development of New Personalised 3D Preclinical Models of

    Recruiting
    • Pancreatic Neuroendocrine Tumor
      • Milan, MI, Italy
        IRCCS San Raffele Institute
      Nov 2, 2023

      Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound Trial in Nanning

      Recruiting
      • Nonfunctional Pancreatic Neuroendocrine Tumor
      • +2 more
      • EUS-guided ethanol ablation
      • EUS-guided lauromacrogol ablation
      • Nanning, Guangxi, China
        First Affiliated Hospital of Guangxi Medical University
      Sep 30, 2022

      Non-functional Neuroendocrine Tumors of Pancreatic Body and Tail

      Recruiting
      • Non Functioning Pancreatic Endocrine Tumor
      • Histopathological review, long-term prognosis and quality of life follow-up
      • Shanghai, Shanghai, China
        Department of Pancreatic Surgery, Fudan University Shanghai Canc
      Jun 8, 2023

      EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

      Recruiting
      • EGFR-Mutated Non-Small-Cell Lung Carcinoma
      • Small Cell/Neuroendocrine
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

      Enrolling by invitation
      • GEP-NET
      • +3 more
      • Copenhagen, Denmark
        Rigshospitalet
      Jan 24, 2023

      Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

      Not yet recruiting
      • Pancreatic Neuroendocrine Tumor
      • Pancreas Cancer
      • cytoreductive surgery
      • +2 more
      • Chicago, Illinois
        The University of Chicago
      Nov 8, 2022

      Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

      Enrolling by invitation
      • Neuroendocrine Tumor Grade 2
      • Neuroendocrine Tumor Grade 1
      • Iowa City, Iowa
        The University of Iowa
      Dec 9, 2022

      Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)

      Recruiting
      • Multiple Endocrine Neoplasia Type 1
      • Pancreatic Neuroendocrine Tumor
      • EUS-guided fine-needle injection
      • Nanning, Guangxi, China
        First Affiliated Hospital of Guangxi Medical University
      Sep 24, 2022

      Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)

      Recruiting
      • Neuroendocrine Tumors
      • Peptide Receptor Radionuclide Therapy
      • Rotterdam, South Holland, Netherlands
        Erasmus MC
      May 19, 2023

      Neuroendocrine Tumors Trial in Copenhagen (One injection of 68Ga-NOTA-AE105, PET/CT)

      Completed
      • Neuroendocrine Tumors
      • One injection of 68Ga-NOTA-AE105
      • PET/CT
      • Copenhagen, Denmark
        Department of Clinical Physiology, Nuclear Medicine and PET, Rig
      Jun 28, 2022

      Rectal Neuroendocrine Tumor Trial (mEMR-C procedure, ESD procedure)

      Not yet recruiting
      • Rectal Neuroendocrine Tumor
      • mEMR-C procedure
      • ESD procedure
      • (no location specified)
      Jun 27, 2022

      Neuroendocrine Tumors Trial in Copenhagen (One injection of 68Ga-NODAGA-E[c(RGDyK)]2, PET/CT)

      Completed
      • Neuroendocrine Tumors
      • One injection of 68Ga-NODAGA-E[c(RGDyK)]2
      • PET/CT
      • Copenhagen, Denmark
        Department of Clinical Physiology, Nuclear Medicine and PET, Rig
      Jun 28, 2022

      Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)

      Recruiting
      • Neuroendocrine Tumors
      • Gallium-68 NODAGA-JR11
      • Beijing, Beijing, China
      • +1 more
      Jul 27, 2022

      Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

      Not yet recruiting
      • Small Cell Lung Cancer (SCLC)
      • +3 more
      • (no location specified)
      Dec 7, 2022

      Gastro-enteropancreatic Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Iowa City (Lutathera, Azedra)

      Not yet recruiting
      • Gastro-enteropancreatic Neuroendocrine Tumor
      • Neuroendocrine Tumors
      • Iowa City, Iowa
        Holden Comprehensive Cancer Center
      Jul 7, 2022

      Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,

      Recruiting
      • Ganglioneuroblastoma
      • +2 more
      • Computed Tomography
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 30, 2023